|Human HER2 / ErbB2 Antibody||Human CD69 Antibody|
|Human 2B4 / CD244 Antibody||Human LAMP1 / CD107a Antibody|
|Human CD13 / ANPEP Antibody||Human CD200R1 Antibody|
|Human BLyS / TNFSF13B / BAFF Antibody||Human RANKL / OPGL / TNFSF11 / CD254 Antibody|
|Human CD155 / PVR / NECL5 Antibody||Human CD19 Antibody|
|Human CD146 / MCAM Antibody||Mouse CD112 / Nectin-2 / PVRL2 Antibody|
|Human CD31 / PECAM1 Antibody||Mouse E-Cadherin / CDH1 / E-cad / CD324 Antibody|
|Human TRAIL R4 / CD264 / TNFRSF10D Antibody||Mouse B7-H3 / CD276 Antibody|
|Human IL3RA / CD123 Antibody||Rat CD48 / SLAMF2 Antibody|
|Human CD208 / DC-LAMP Antibody||Rat B7-H3 / CD276 Antibody|
|Human EpCAM / TROP-1 / TACSTD1 Antibody||Cynomolgus CD166 / ALCAM Antibody|
|Human DDR1 Kinase / MCK10 / CD167 Antibody||Cynomolgus EpCAM / TROP-1 / TACSTD1 Antibody|
|Human CD3d / CD3 delta Antibody||Human CD7 Antibody|
The cluster of differentiation (or cluster of designation), often abbreviated as CD, is a protocol used for the identification and investigation of cell surface molecules present on white blood cells. The cluster of differentiation nomenclature was proposed for the classification of the many monoclonal antibodies generated by different laboratories around the world against epitopes on the surface molecules of leukocytes. Since then, the use of cluster of differentiation has expanded to many other cell types.
Immunoprecipitation is a technique in which an antigen is isolated by binding to a specific antibody attached to a sedimentable matrix. An antibody (monoclonal or polyclonal) against a specific protein is pre-immobilized onto an insoluble support, such as agarose or magnetic beads, and then incubated with a cell lysate containing the target protein. During the incubation period, gentle agitation of the lysate allows the target antigen to bind to the immobilized antibody. The immobilized immune complexes are then collected from the lysate, eluted from the support and analyzed based on the nature of the target antigen.